Global Nasogastric Tube Market Research Report by Patient Type (Adult, Pediatric, Geriatric), by Type (Small-bore feeding tubes, Large-bore feeding tubes) by Indication (Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia, Others), by End User(Hospitals & Nursing Homes, Home Care) by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19.
Report ID : IR1001083 | Industries : Healthcare | Published On :May 2024 | Page Count : 242
Global Nasogastric Tube Market Research Report by Patient Type (Adult, Pediatric, Geriatric), by Type (Small-bore feeding tubes, Large-bore feeding tubes) by Indication (Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia, Others), by End User(Hospitals & Nursing Homes, Home Care) by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19.
Global Nasogastric Tube Market
The global Nasogastric Tube market was valued at USD 525.1 million in 2021 which expected to reach USD 754.5 million by 2027 at a CAGR 5.41 % from 2022-2027.
The nose, nasopharynx, and throat are used to insert a nasogastric tube (NG) into the stomach. Plastic and elastic are combined to create a flexible tube with bidirectional potential. Up to six weeks can pass while using these devices for enteral feeding. NG tubes are also routinely used to provide medications and nourishment, add contrast to the stomach for X-rays, remove air or liquids from the stomach, and protect the colon after surgery or when on bowel rest. Hence fueling market expansion.
Market Drivers
The prevalence of chronic diseases is expected to raise demand for nasogastric tubes, which is expected to drive the growth of the global market. The increase in patients suffering from malnutrition around the world is another significant element that will favourably influence market growth. For instance, 2 million people worldwide lack vital micronutrients like vitamins, according to a World Health Organization research. Malnutrition, which has higher mortality and morbidity rates, affects 40% of hospitalized patients, according to the same study. In order to provide malnourished persons and those unable to consume nutrients orally with an adequate amount of nutrition, nasogastric tubes are the first line of defence.
Impact of COVID-19
Nasogastric tubes were in higher demand in North America as a result of the COVID-19 outbreak. In North America, an increase in COVID-19 patient admissions was accompanied by a corresponding rise in ICU admissions. Moreover, enteral nutrition was provided to the majority of ICU patients via these devices. As a result, during the pandemic, ICU patients increased their use of and demand for these tubes. However because the medical community is now concentrating on treating COVID-19, funding for enteral nutrition-related R&D efforts has declined.
Market Segmentation
The Global Nasogastric Tube Market is segmented into Patient Type, Type Indication, and End-use. Based on the Indication, the market is segmented into Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia, Others. Further, market is segmented into The End-use, the market is segmented into near Hospitals & Nursing Homes, Home Care. By Type, the market is segmented into Small-bore feeding tubes, Large-bore feeding tubes. By Patient Type, the market is segmented into Adult, Pediatric, and Geriatric.
Regional Analysis
Global Nasogastric Tube Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America led the market, accounting for the largest share of revenue. Due to the creation of numerous regulatory rules in the region, the North American region is anticipated to have strong demand over the projected period. For instance, the U.S. FDA published recommendations in June 2021 for determining whether oral pharmaceutical medications are suitable for use with enteral feeding tubes. These developments increase the demand for effective nasogastric tubes, which may be necessary to maintain enough nourishment for a range of conditions, such as cancer, swallowing difficulties, severe hereditary or acquired neurological dysfunction, and other disorders.
Key Players
Various key players are listed in this report such as QMD, Angiplast Pvt. Ltd., Securmed, Vygon, Medtronic, Andersen Products Inc., Cardinal Health, Baihe Medical, Poly Medicure Limited.
Market Taxonomy
By Patient Type
• Adult
• Pediatric
• Geriatric
By Type
• Small-bore feeding tubes
• Large-bore feeding tubes
By Indication
• Stomach Cancer
• Esophageal Cancer
• IBD
• Chronic Kidney Disease
• Dysphagia
• Others
By End-use
• Hospitals & Nursing Homes
• Home Care
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Nasogastric Tube Market?
• What will be the growth rate from 2022 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
Global Nasogastric Tube Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Nasogastric Tube Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Nasogastric Tube Market, By Patient Type
5.1 Y-o-Y Growth Comparison, By Patient Type
5.2 Global Nasogastric Tube Market Share Analysis, By Patient Type
5.3 Global Nasogastric Tube Market Size and Forecast, By Patient Type
5.3.1 Adult
5.3.2 Pediatric
5.3.3 Geriatric
6 Global Nasogastric Tube Market, By Type
6.1 Y-o-Y Growth Comparison, By Type
6.2 Global Nasogastric Tube Market Share Analysis, By Type
6.3 Global Nasogastric Tube Market Size and Forecast, By Type
6.3.1 Small-bore feeding tubes
6.3.2 Large-bore feeding tubes
7 Global Nasogastric Tube Market, By Indication
7.1 Y-o-Y Growth Comparison, By Indication
7.2 Global Nasogastric Tube Market Share Analysis, By Indication
7.3 Global Nasogastric Tube Market Size and Forecast, By Indication
7.3.1 Stomach Cancer
7.3.2 Esophageal Cancer
7.3.3 IBD
7.3.4 Chronic Kidney Disease
7.3.5 Dysphagia
7.3.6 Others
8 Global Nasogastric Tube Market, By End-use
8.1 Y-O-Y Growth Comparison, By End-use
8.2 Global Nasogastric Tube Market Share Analysis, By End-use
8.3 Global Nasogastric Tube Market Size and Forecast, By End-use
8.3.1 Hospitals & Nursing Homes
8.3.2 Home Care
9 Global Nasogastric Tube Market, By Region
9.1 Global Nasogastric Tube Market Share Analysis, By Region
9.2 Global Nasogastric Tube Market Share Analysis, By Region
9.3 Global Nasogastric Tube Market Size and Forecast, By Region
10 North America Nasogastric Tube Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 North America Nasogastric Tube Market Share Analysis, By Patient Type
10.3 North America Nasogastric Tube Market Size and Forecast, By Type
10.4 North America Nasogastric Tube Market Size and Forecast, By Indication
10.5 North America Nasogastric Tube Market Size and Forecast, By End-use
10.6 North America Nasogastric Tube Market Size and Forecast, By Country
10.7.1 U.S.
10.7.2 Canada
10.7.3 Mexico
11 Europe Nasogastric Tube Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Europe Nasogastric Tube Market Share Analysis, By Patient Type
11.3 Europe Nasogastric Tube Market Size and Forecast, By Type
11.4 Europe Nasogastric Tube Market Size and Forecast, By Indication
11.5 Europe Nasogastric Tube Market Size and Forecast, By End-use
11.6 Europe Nasogastric Tube Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.6.4. Rest of Europe
12 Asia Pacific Nasogastric Tube Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Asia Pacific Nasogastric Tube Market Share Analysis, By Patient Type
12.3 Asia Pacific Nasogastric Tube Market Size and Forecast, By Type
12.4 Asia Pacific Nasogastric Tube Market Size and Forecast, By Indication
12.5 Asia Pacific Nasogastric Tube Market Size and Forecast, By End-use
12.6 Asia Pacific Nasogastric Tube Market Size and Forecast, By Country
12.6.1 China
12.7.2 Japan
12.8.3 India
12.9.4. Rest of Asia Pacific
13 Latin America Nasogastric Tube Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Latin America Nasogastric Tube Market Share Analysis, By Patient Type
13.3 Latin America Nasogastric Tube Market Size and Forecast, By Type
13.4 Latin America Nasogastric Tube Market Size and Forecast, By Indication
13.5 Latin America Nasogastric Tube Market Size and Forecast, By End-use
13.6 Latin America Nasogastric Tube Market Size and Forecast, Country
13.7.1. Brazil
13.8.2. Rest of Latin America
14 Middle East Nasogastric Tube Market Analysis and Forecast (2022-2027)
14.1 Introduction
14.2 Middle East Nasogastric Tube Market Share Analysis, By Patient Type
14.3 Middle East Nasogastric Tube Market Size and Forecast, By Type
14.4 Middle East Nasogastric Tube Market Size and Forecast, By Indication
14.5 Middle East Nasogastric Tube Market Size and Forecast, By End-use
14.6 Middle East Nasogastric Tube Market Size and Forecast, By Country
14.7.1. Saudi Arabia
14.8.2. UAE
14.9.3. Egypt
14.10.4. Kuwait
14.11.5. South Africa
15Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 QMD
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2. Angiplast Pvt. Ltd.
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3. Securmed
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Vygon
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Medtronic
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Andersen Products Inc.
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Cardinal Health
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 Baihe Medical
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 Poly Medicure Limited
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies